Clinical Research Directory

Inclusion Criteria: * be accompanied by a parent or guardian who is able to read and comprehend Vietnamese/English and sign a record of informed consent/assent; * at baseline, be within the age range of 7 to 13 years old inclusive; * be diagnosed as myopic having cycloplegic spherical equivalent between -0.75 dioptre (D) and -5.00 dioptre (D); * astigmatism ≤1.50D; * anisometropia of not more than 1.50D; * be willing to comply with the wearing of clinical trial spectacles and clinical trial visit schedule as directed by the investigator; * have ocular findings deemed to be normal; * vision correctable to at least 0.8 or better in each eye with spectacles. Exclusion Criteria: * Any pre-existing systemic or ocular condition, including infection or disease that is likely to affect visual acuity and refractive error; * Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. * Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant's ocular health / physiology in an adverse or beneficial manner at enrolment and/or during the clinical trial. NB: Systemic antihistamines are allowed on an "as needed basis", provided they are not used prophylactically during the trial and at least 24 hours before the clinical trial product is used. * History of eye trauma or eye surgery * Amblyopia * Anisometropia of not more than 1.50D * Strabismus * History of use of myopia control interventions such as Orthokeratology or atropine 3 months prior to commencement of this trial. * Known allergy or intolerance to ingredients to cycloplegic eye-drops. * Currently enrolled in another clinical trial.